Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step

By sjmartinez • November 18, 2024

Khan S, Yancy CW, Fonarow GC. Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step. JAMA Cardiol. 2024 Nov 17. doi: 10.1001/jamacardio.2024.4624. Epub ahead of print. PMID: 39550719.

Tags: Cardiology/Epi, Publications

Related Posts

Immunomodulatory Microneedle Patch for Cardiac Repair in Rodent and Porcine Models of Myocardial Infarction

Huang K, Zhu D, Soto J, Hu S, Fang J, Huang J, Zhang X, Li J, Li Y, Tasoudis P, Liu S, Mei X, Hoffman[...]

One-year outcomes of the RESILIA balloon-expandable transcatheter valve: survival, hemodynamics, and hypoattenuated leaflet thickening

Suruga K, Patel V, Guo Y, Shitan H, Ng D, Nagasaka T, Menda J, Singh A, Gheorghiu M, Patel D, Gupta A, Chakravarty T, Cheng[...]

Optimization of Image Quality for Quantitative Multi-Contrast Atherosclerosis Characterization (qMATCH): Comparison Between Transverse and Coronal Acquisitions

Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]